Lowering pain and inflammation drug costs: evaluating the impact of a cost plus drug company model

Kaylyn Rowsey; Adam Khan; Jillian Brassfield; Matthew Rashid; Jacob Duncan; Matt Vassar

doi:10.1093/pm/pnaf034

Lowering pain and inflammation drug costs: evaluating the impact of a cost plus drug company model

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	607-610
Number of pages	4
Journal	Pain Medicine (United States)
Volume	26
Issue number	9
DOIs	https://doi.org/10.1093/pm/pnaf034
State	Published - 1 Sep 2025

Access to Document

10.1093/pm/pnaf034

Cite this

@article{d4ce41bfb2dc412a9654abbe8a835159,

title = "Lowering pain and inflammation drug costs: evaluating the impact of a cost plus drug company model",

author = "Kaylyn Rowsey and Adam Khan and Jillian Brassfield and Matthew Rashid and Jacob Duncan and Matt Vassar",

year = "2025",

month = sep,

day = "1",

doi = "10.1093/pm/pnaf034",

language = "English",

volume = "26",

pages = "607--610",

journal = "Pain Medicine (United States)",

issn = "1526-2375",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Lowering pain and inflammation drug costs

T2 - evaluating the impact of a cost plus drug company model

AU - Rowsey, Kaylyn

AU - Khan, Adam

AU - Brassfield, Jillian

AU - Rashid, Matthew

AU - Duncan, Jacob

AU - Vassar, Matt

PY - 2025/9/1

Y1 - 2025/9/1

UR - https://www.scopus.com/pages/publications/105015218511

U2 - 10.1093/pm/pnaf034

DO - 10.1093/pm/pnaf034

M3 - Letter

C2 - 40139720

AN - SCOPUS:105015218511

SN - 1526-2375

VL - 26

SP - 607

EP - 610

JO - Pain Medicine (United States)

JF - Pain Medicine (United States)

IS - 9

ER -

Lowering pain and inflammation drug costs: evaluating the impact of a cost plus drug company model

Access to Document

Other files and links

Cite this